latest news releases from the newsroom
Bioheart Files for Reimbursement Approval in Europe for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure
SUNRISE, Fla., Dec. 1, 2008 (GLOBE NEWSWIRE) -- Bioheart, Inc. (Nasdaq:BHRT) announced today it has filed with appropriate agencies in Italy, Germany and the Netherlands for reimbursement approval for its MyoCell(r) myogenic cell therapy for heart failure. This patented composition and method has been studied in clinical trials involving more than 350 patients to date at over 100 centers worldwide since the year 2000. Data from one of these trials conducted by Bioheart indicates that about 84 percent of the myogenic stem cell treated patients improved in exercise capacity. In comparison, only 31 percent of the control patients on heart failure drugs improved.
WaveBox Portable Microwave Offers Free Holiday Shipping
ASHEVILLE, N.C., Dec. 1, 2008 (GLOBE NEWSWIRE) -- Anyone wanting to make the new WaveBox portable microwave the perfect holiday gift can get free shipping valued at $29 by placing their order on the WaveBox Web store at www.thewavebox.com.
Meehan Capital Management Group, Inc.
Meehan Capital Releases Equity Update On CryoPort, Inc.
ORLANDO, Fla., Dec. 1, 2008 (GLOBE NEWSWIRE) -- Meehan Capital Management Group, Inc., a Florida-based Registered Investment Advisor, announced today that it has released an equity update discussing the recent announcements at CryoPort, Inc. (OTCBB:CYRX) and its disclosure of global business alliances with FedEx Corporation (NYSE:FDX), Quest Diagnostics, Inc. (NYSE:DGX) and Air Liquide (XETRA:AIR.DE).
Semi-Annual Review of NASDAQ OMX Carbon Indexes
STOCKHOLM, Sweden, Dec. 1, 2008 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. ("NASDAQ") (Nasdaq:NDAQ) announced the results of the semi-annual review of the NASDAQ OMX Carbon Indexes (Nasdaq:NOCO) became effective with the market open on Monday, December 1, 2008.